Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 32

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis

Aleem, Daniyal, Tohid, Hassaan · 2018 · Revista Colombiana de Psiquiatría

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.rcp.2017.03.002

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 117

  1. Brown, 2015, Psychodermatology, Adv Psychosom Med., 34, 123, 10.1159/000369090 · DOI
  2. Leon, 2013, Psychodermatology: an overview, Semin Cutan Med Surg., 32, 64, 10.12788/j.sder.0002 · DOI
  3. White, 2015, Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study, Circulation., 132, 1630, 10.1161/CIRCULATIONAHA.114.014443 · DOI
  4. Bisschop, 2004, The longitudinal relation between chronic diseases and depression in older persons in the community: the Longitudinal Aging Study Amsterdam, J Clin Epidemiol., 57, 187, 10.1016/j.jclinepi.2003.01.001 · DOI · Paper page
  5. Krishnan, 2002, Comorbidity of depression with other medical diseases in the elderly, Biol Psychiatry, 52, 559, 10.1016/S0006-3223(02)01472-5 · DOI · Paper page
  6. Nicholson, 2006, Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6,362 events among 146,583 participants in 54 observational studies, Eur Heart J., 27, 2763, 10.1093/eurheartj/ehl338 · DOI · Paper page
  7. Nasir, 2015, Sleep quality and depression in hospitalized congestive heart failure patients, J Pak Med Assoc., 65, 264
  8. Krishnadas, 2016, Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans, Brain Behav Immun., 51, 29, 10.1016/j.bbi.2015.08.005 · DOI
  9. Esposito, 2006, An Italian study on psoriasis and depression, Dermatology., 212, 123, 10.1159/000090652 · DOI · Paper page
  10. Akay, 2002, Assessment of depression in subjects with psoriasis vulgaris and lichen planus, J Eur Acad Dermatol Venereol., 16, 347, 10.1046/j.1468-3083.2002.00467.x · DOI · Paper page
  11. Gupta, 1989, A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients, Gen Hosp Psychiatry., 11, 166, 10.1016/0163-8343(89)90036-4 · DOI
  12. Gupta, 1994, Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria, Psychosom Med., 56, 36, 10.1097/00006842-199401000-00005 · DOI · Paper page
  13. Fordham, 2015, A pilot study examining mindfulness-based cognitive therapy in psoriasis, Psychol Health Med., 20, 121, 10.1080/13548506.2014.902483 · DOI · Paper page
  14. Polenghi, 1994, Experience with psoriasis in a psychosomatic dermatology clinic, Acta Derm Venereol Suppl (Stockh)., 186, 65
  15. Menter, 2010, The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial, J Am Acad Dermatol., 62, 812, 10.1016/j.jaad.2009.07.022 · DOI · Paper page
  16. Fortune, 2002, A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy, Br J Dermatol., 146, 458, 10.1046/j.1365-2133.2002.04622.x · DOI · Paper page
  17. Mease, 2010, Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials, Dermatology., 220, 1, 10.1159/000260371 · doi:10.1159/000260371
  18. Redighieri, 2011, Erythrodermic psoriasis with regression after prophylaxis with isoniazid and antidepressant therapy: case report, An Bras Dermatol., 86, S141, 10.1590/S0365-05962011000700037 · doi:10.1590/s0365-05962011000700037
  19. Van Voorhees, 2009, Depression and quality of life in psoriasis, Postgrad Med., 121, 154, 10.3810/pgm.2009.07.2040 · DOI
  20. Palfreeman, 2013, New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast, Drug Des Devel Ther., 7, 201, 10.2147/DDDT.S32713 · DOI
  21. Cedeno-Laurent, 2011, New insights into HIV-1 primary skin disorders, J Int AIDS Soc., 14, 5, 10.1186/1758-2652-14-5 · DOI · Paper page
  22. van Beelen, 2007, Interleukin-17 in inflammatory skin disorders, Curr Opin Allergy Clin Immunol., 7, 374, 10.1097/ACI.0b013e3282ef869e · DOI · Paper page
  23. Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature., 445, 648, 10.1038/nature05505 · DOI · Paper page
  24. Lowes, 2008, Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17T cells, J Invest Dermatol., 128, 1207, 10.1038/sj.jid.5701213 · DOI · Paper page
  25. Ouyang, 2010, Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease, Cytokine Growth Factor Rev., 21, 435, 10.1016/j.cytogfr.2010.10.007 · DOI
  26. Uyemura, 1993, The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response, J Invest Dermatol., 101, 701, 10.1111/1523-1747.ep12371679 · DOI · Paper page
  27. Korver, 2006, Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis, Br J Dermatol., 155, 688, 10.1111/j.1365-2133.2006.07403.x · DOI
  28. Vissers, 2004, The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis, Exp Dermatol., 13, 106, 10.1111/j.0906-6705.2004.00151.x · doi:10.1111/j.0906-6705.2004.00151.x
  29. Raychaudhuri, 2014, Diagnosis and classification of psoriasis, Autoimmun Rev., 13, 490, 10.1016/j.autrev.2014.01.008 · DOI · Paper page
  30. Parrish L. Psoriasis: symptoms, treatments and its impact on quality of life. Br J Community Nurs. 2012;17:524,526,528. · doi:10.12968/bjcn.2012.17.11.524
  31. Nestle, 2009, Psoriasis, N Engl J Med, 361, 496, 10.1056/NEJMra0804595 · DOI · Paper page
  32. Urpe, 2005, Stress and psychoneuroimmunologic factors in dermatology, Dermatol Clin., 23, 609, 10.1016/j.det.2005.05.017 · DOI
  33. Halevy, 1993, Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism, J Am Acad Dermatol., 29, 504, 10.1016/S0190-9622(08)82012-9 · doi:10.1016/s0190-9622(08)82012-9
  34. Steinkraus, 1993, Beta-adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin, Arch Dermatol Res., 285, 300, 10.1007/BF00371601 · doi:10.1007/bf00371601
  35. Farber, 1990, The role of cutaneous sensory nerves in the maintenance of psoriasis, Int J Dermatol., 29, 418, 10.1111/j.1365-4362.1990.tb03825.x · doi:10.1111/j.1365-4362.1990.tb03825.x
  36. Raychaudhuri, 2000, Role of nerve growth factor in RANTES expression by keratinocytes, Acta Derm Venereol., 80, 247, 10.1080/000155500750012108 · doi:10.1080/000155500750012108
  37. Farber, 1993, Psoriasis: a stress-related disease, Cutis., 51, 322
  38. Farber, 1986, Stress, symmetry, and psoriasis: possible role of neuropeptides, J Am Acad Dermatol, 14, 305, 10.1016/S0190-9622(86)70034-0 · DOI · Paper page
  39. Nickoloff, 2000, Is psoriasis a T-cell disease?, Exp Dermatol., 9, 359, 10.1034/j.1600-0625.2000.009005359.x · DOI
  40. Raychaudhuri, 2000, Nerve growth factor and its receptor system in psoriasis, Br J Dermatol., 143, 198, 10.1046/j.1365-2133.2000.03617.x · doi:10.1046/j.1365-2133.2000.03617.x
  41. Aloe, 2002, Stress and nerve growth factor: findings in animal models and humans, Pharmacol Biochem Behav., 73, 159, 10.1016/S0091-3057(02)00757-8 · DOI
  42. Brunoni, 2015, Decreased brainderived neurotrophic factor plasma levels in psoriasis patients, Braz J Med Biol Res., 48, 711, 10.1590/1414-431X20154574 · DOI
  43. Owczarczyk-Saczonek, 2017, Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders, Int J Dermatol., 56, 260, 10.1111/ijd.13420 · DOI
  44. Campa, 2016, A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies, Expert Opin Investig Drugs., 25, 1337, 10.1080/13543784.2016.1237502 · DOI
  45. Wasilewska, 2016, Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases, Postepy Dermatol Alergol., 33, 247, 10.5114/ada.2016.61599 · DOI
  46. Maes, 1995, Evidence for an immune response in major depression: a review and hypothesis, Prog Neuropsychopharmacol Biol Psychiatry., 19, 11, 10.1016/0278-5846(94)00101-M · DOI · Paper page
  47. Angiolillo, 1995, Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo, J Exp Med., 182, 155, 10.1084/jem.182.1.155 · DOI · Paper page
  48. Xia, 1996, Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells, Immunopharmacology., 34, 27, 10.1016/0162-3109(96)00111-7 · DOI · Paper page
  49. Maes, 1999, Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion, Neuropsychopharmacology., 20, 370, 10.1016/S0893-133X(98)00088-8 · DOI · Paper page
  50. Cattaneo, 2013, Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’, Neuropsychopharmacology., 38, 377, 10.1038/npp.2012.191 · DOI · Paper page
  51. Miller, 2008, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biol Psychiatry., 65, 732, 10.1016/j.biopsych.2008.11.029 · DOI · Paper page
  52. Miller, 2008, Immune system contributions to the pathophysiology of depression, Focus., 6, 36, 10.1176/foc.6.1.foc36 · DOI
  53. Rosenblat, 2014, Inflamed moods: a review of the interactions between inflammation and mood disorders, Prog Neuropsychopharmacol Biol Psychiatry., 53, 23, 10.1016/j.pnpbp.2014.01.013 · DOI · Paper page
  54. Motivala, 2005, Inflammatory markers and sleep disturbance in major depression, Psychosom Med., 67, 187, 10.1097/01.psy.0000149259.72488.09 · DOI · Paper page
  55. Hannestad, 2011, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis, Neuropsychopharmacology., 36, 2452, 10.1038/npp.2011.132 · DOI · Paper page
  56. Moon, 2013, Psoriasis and psycho-dermatology, Dermatol Ther (Heidelb), 3, 117, 10.1007/s13555-013-0031-0 · DOI
  57. Moller, 2012, Social isolation rearing induces immunological, neurochemical, mitochondrial and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine, Brain Behav Immun., 18, 156
  58. Persoons, 1995, Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently, Am J Respir Crit Care Med., 152, 619, 10.1164/ajrccm.152.2.7633716 · DOI
  59. Nguyen, 1998, Exposure to acute stress induces brain interleukin-1beta protein in the rat, J Neurosci., 18, 2239, 10.1523/JNEUROSCI.18-06-02239.1998 · DOI · Paper page
  60. Maier, 1995, Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock, Brain Res., 695, 279, 10.1016/0006-8993(95)00930-O · DOI · Paper page
  61. Kubera, 1996, Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression, Pol J Pharmacol., 48, 503
  62. Kubera, 2011, In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression, Prog Neuropsychopharmacol Biol Psychiatry., 35, 744, 10.1016/j.pnpbp.2010.08.026 · DOI · Paper page
  63. Bouhuys, 2004, Potential psychosocial mechanisms linking depression to immune function in elderly subjects, Psychiatry Res., 127, 237, 10.1016/j.psychres.2004.05.001 · DOI
  64. Musselman, 2001, Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings, Am J Psychiatry., 158, 1252, 10.1176/appi.ajp.158.8.1252 · DOI · Paper page
  65. Kahl, 2005, Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder, Am J Psychiatry., 162, 168, 10.1176/appi.ajp.162.1.168 · DOI
  66. Tiemeier, 2003, Inflammatory proteins and depression in the elderly, Epidemiology., 14, 103, 10.1097/00001648-200301000-00025 · DOI · Paper page
  67. Schlatter, 2004, Monocytic parameters in patients with dysthymia versus major depression, J Affect Disord., 78, 243, 10.1016/S0165-0327(02)00316-6 · DOI
  68. Levine, 1999, Cerebrospinal cytokine levels in patients with acute depression, Neuropsychobiology., 40, 171, 10.1159/000026615 · DOI · Paper page
  69. Rajagopalan, 2001, Abnormal brachial artery flow-mediated vasodilation in young adults with major depression, Am J Cardiol., 88, 196, 10.1016/S0002-9149(01)01623-X · DOI · Paper page
  70. Sluzewska, 1995, Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine, Ann NY Acad Sci., 762, 474, 10.1111/j.1749-6632.1995.tb32372.x · DOI · Paper page
  71. Maes, 1997, Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression, Cytokine., 9, 853, 10.1006/cyto.1997.0238 · DOI · Paper page
  72. Mikova, 2001, Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis, Eur Neuropsychopharmacol., 11, 203, 10.1016/S0924-977X(01)00081-5 · DOI · Paper page
  73. Sluzewska, 1997, Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression, Neuropsychobiology., 35, 123, 10.1159/000119332 · DOI · Paper page
  74. Tuglu, 2003, Increased serum tumor necrosis factor- α levels and treatment response in major depressive disorder, Psychopharmacology (Berl)., 170, 429, 10.1007/s00213-003-1566-z · DOI · Paper page
  75. Owen, 2001, Raised levels of plasma interleukin-1beta in major and postviral depression, Acta Psychiatr Scand., 103, 226, 10.1034/j.1600-0447.2001.00162.x · DOI · Paper page
  76. Thomas, 2005, Increase in interleukin-1β in late-life depression, Am J Psychiatry., 162, 175, 10.1176/appi.ajp.162.1.175 · DOI · Paper page
  77. Raison, 2006, Cytokines sing the blues: inflammation and the pathogenesis of depression, Trends Immunol., 27, 24, 10.1016/j.it.2005.11.006 · DOI · Paper page
  78. Bonaccorso, 2002, Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus, J Affect Disord., 72, 237, 10.1016/S0165-0327(02)00264-1 · DOI · Paper page
  79. Lotrich, 2009, Major depression during interferon-α treatment: vulnerability and prevention, Dial Clin Neurosci., 11, 417, 10.31887/DCNS.2009.11.4/felotrich · DOI
  80. Beretta, 2008, A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation, Arthritis Res Ther., 10, R103, 10.1186/ar2495 · doi:10.1186/ar2495
  81. Dunn, 2005, Cytokines as mediators of depression: what can we learn from animal studies?, Neurosci Biobehav Rev, 29, 891, 10.1016/j.neubiorev.2005.03.023 · DOI · Paper page
  82. Maes, 2011, Prog Neuro-Psychopharmacol Biol Psychiatry., 35, 702, 10.1016/j.pnpbp.2010.12.017 · DOI · Paper page
  83. Wang, 1998, Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism, Neurochem Int., 33, 143, 10.1016/S0197-0186(98)00016-3 · DOI
  84. Maes, 2011, Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways, Neuro Endocrinol Lett., 32, 7
  85. Al’Abadie, 1994, The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions, Br J Dermatol., 130, 199, 10.1111/j.1365-2133.1994.tb02900.x · DOI · Paper page
  86. Devrimci-Ozguven, 2000, The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients, J Eur Acad Dermatol Venereol., 14, 267, 10.1046/j.1468-3083.2000.00085.x · DOI · Paper page
  87. Magin, 2008, Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study, Scand J Caring Sci., 22, 430, 10.1111/j.1471-6712.2007.00547.x · DOI
  88. Fava, 1980, Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections, Br J Med Psychol., 53, 277, 10.1111/j.2044-8341.1980.tb02551.x · DOI · Paper page
  89. Gupta, 1993, Suicidal ideation in psoriasis, Int J Dermatol., 32, 188, 10.1111/j.1365-4362.1993.tb02790.x · DOI · Paper page
  90. Hardy, 1982, A study of depression and obsessionality in dysmorphophobic and psoriatic patients, Br J Psychiatry., 140, 19, 10.1192/bjp.140.1.19 · DOI
  91. Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol Psychiatry., 67, 446, 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
  92. Breuer, 2016, Relationship between chronic stress and CRP levels in women with psoriasis, J Dtsch Dermatol Ges., 14, 528
  93. Schmid-Ott, 2009, Immunological effects of stress in psoriasis, Br J Dermatol., 160, 782, 10.1111/j.1365-2133.2008.09013.x · DOI
  94. Brown, 1987, Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients, Acta Psychiatr Scand., 76, 272, 10.1111/j.1600-0447.1987.tb02895.x · DOI
  95. Kartha, 2014, Serum melatonin levels in psoriasis and associated depressive symptoms, Clin Chem Lab Med., 52, 1, 10.1515/cclm-2013-0957 · DOI
  96. Sandyk, 1990, Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin, Int J Neurosci., 50, 215, 10.3109/00207459008987174 · DOI
  97. Carrillo-Vico, 2013, Melatonin: buffering the immune system, Int J Mol Sci., 14, 8638, 10.3390/ijms14048638 · DOI · Paper page
  98. Esposito, 2010, Anti-inflammatory activity of melatonin in central nervous system, Curr Neuropharmacol., 8, 228, 10.2174/157015910792246155 · DOI · Paper page
  99. Mozzanica, 1988, Plasma melatonin levels in psoriasis, Acta Derm Venereol., 68, 312
  100. Miles, 1987, Melatonin: perspectives in laboratory medicine and clinical research, Crit Rev Clin Lab Sci., 25, 231, 10.3109/10408368709105884 · DOI
  101. Ozler, 2010, Comparison of the effect of topical and systemic melatonin administration on delayed wound healing in rats that underwent pinealectomy, Scand J Clin Lab Invest., 70, 447, 10.3109/00365513.2010.506926 · DOI
  102. Sandyk, 1990, Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin, Int J Neurosci, 50, 215, 10.3109/00207459008987174 · DOI
  103. Johnson, 1996, PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes, Photochem Photobiol., 63, 566, 10.1111/j.1751-1097.1996.tb05657.x · DOI
  104. Laing, 1995, Ultraviolet light and 8-methoxypsoralen inhibit expression of endothelial adhesion molecules, J Rheumatol., 22, 2126
  105. Sethi, 2004, Role of p38 mitogen-activated protein kinase and caspases in UV-B-induced apoptosis of murine peritoneal macrophages, Photochem Photobiol., 79, 48
  106. Singh, 2010, 8-Methoxypsoralen plus ultraviolet a therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder, J Immunol., 184, 7257, 10.4049/jimmunol.0903719 · DOI
  107. Diffey, 1980, Ultraviolet radiation physics and the skin, Phys Med Biol., 25, 405, 10.1088/0031-9155/25/3/001 · DOI
  108. Kannan, 2013, The role of tumor necrosis factor-α and other cytokines in depression: what dermatologists should know, J Dermatolog Treat., 24, 148, 10.3109/09546634.2011.619159 · DOI
  109. Golpour, 2012, Depression and anxiety disorders among patients with psoriasis: a hospitalbased case-control study, Dermatol Res Pract., 2012, 381905, 10.1155/2012/381905 · DOI
  110. Demirhan, 2012, Identification of chromosome abnormalities in screening of a family with manic depression and psoriasis: predisposition to aneuploidy, Asian J Psychiatr., 5, 169, 10.1016/j.ajp.2012.02.005 · DOI
  111. Tohid, 2016, A Psychodermatological Phenomenon, Skin Pharmacol Physiol., 29, 220, 10.1159/000448122 · DOI
  112. Pompili, 2016, Suicide risk and psychiatric comorbidity in patients with psoriasis, J Int Med Res., 44, 61, 10.1177/0300060515593253 · DOI
  113. Sbidian, 2016, Suicide and psoriasis: no longer an association, Br J Dermatol., 175, 456, 10.1111/bjd.14900 · doi:10.1111/bjd.14900
  114. Gooderham, 2016, A Review of Psoriasis, Therapies, and Suicide, J Cutan Med Surg., 20, 293, 10.1177/1203475416648323 · DOI
  115. Innamorati, 2016, Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis, Compr Psychiatry., 70, 200, 10.1016/j.comppsych.2016.08.001 · DOI
  116. Gravani, 2014, Synthetic antimalarial drugs and the triggering of psoriasis — do we need disease-specific guidelines for the management of patients with psoriasis at risk of malaria?, Int J Dermatol., 53, 327, 10.1111/ijd.12231 · DOI
  117. Fry, 2007, Triggering psoriasis: the role of infections and medications, Clin Dermatol., 25, 606, 10.1016/j.clindermatol.2007.08.015 · DOI · Paper page

Cited by

See all 32

Metadata

Authors
Aleem, D., & Tohid, H.
Venue
Revista Colombiana de Psiquiatría
Publisher
Elsevier BV
Published
2018-07
Volume
47
Issue
3
Pages
177-186
ISSN
0034-7450
Cited by
32
References
20
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.